Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot study

25-Hydroxy-Vitamin D Status: Limitations in Comparison and Clinical Interpretation of Serum-Levels Across Different Assay Methods

(2016) Dietmar Enko et al.   Clinical Laboratory

Nutrition Facts in Multiple Sclerosis

(2015) Paolo Riccio et al.   ASN Neuro

Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome

(2015) Charles N. Serhan et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses

(2015) Lazaros Belbasis et al.   LANCET NEUROLOGY

TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis

(2015) Alessandro Trentini et al.   Multiple Sclerosis Journal

Defining the clinical course of multiple sclerosis: The 2013 revisions

(2015) F. H. Jacques et al.   NEUROLOGY

Increased Circulating Levels of Vitamin D Binding Protein in MS Patients

(2015) Arturo Rinaldi et al.   Toxins

TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis

(2015) Alessandro Trentini et al.   Multiple Sclerosis Journal

Current Perspectives on Interferon Beta-1b for the Treatment of Multiple Sclerosis

(2014) Martin Marziniak et al.   ADVANCES IN THERAPY

Relapsing and progressive forms of multiple sclerosis

(2014) Ranjan Dutta et al.   CURRENT OPINION IN NEUROLOGY

Current and Future Therapies Targeting the Immune System in Multiple Sclerosis

(2014) Verena Loleit et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Vitamin D, immune regulation, the microbiota, and inflammatory bowel disease

(2014) Margherita T Cantorna et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Single nucleotide polymorphisms of vitamin D binding protein, vitamin D receptor and retinoid X receptor alpha genes and response to hepatitis B vaccination in renal replacement therapy patients

(2014) Alicja E Grzegorzewska et al.   Expert Review of Vaccines

A Multimodal Intervention for Patients with Secondary Progressive Multiple Sclerosis: Feasibility and Effect on Fatigue

(2014) Babita Bisht et al.   JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE

From classic to spontaneous and humanized models of multiple sclerosis: Impact on understanding pathogenesis and drug development

(2014) Avraham Ben-Nun et al.   JOURNAL OF AUTOIMMUNITY

Vitamin D and brain health: the need for vitamin D supplementation and sensible sun exposure

(2014) M. F. Holick   JOURNAL OF INTERNAL MEDICINE

Serum 25(OH)D response to vitamin D3 supplementation: A meta-regression analysis

(2014) Sakineh Shab-Bidar et al.   NUTRITION

Vitamin D Receptor Gene Polymorphisms Are Associated with Obesity and Inflammosome Activity

(2014) Nasser M. Al-Daghri et al.   PLoS One

Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression

(2014) Alberto Ascherio et al.   JAMA Neurology

Immunomodulatory activity of interferon-beta

(2014) Lloyd H. Kasper et al.   Annals of Clinical and Translational Neurology

Vitamin D receptor ChIP-seq in primary CD4+ cells: relationship to serum 25-hydroxyvitamin D levels and autoimmune disease

(2013) Adam E Handel et al.   BMC Medicine

Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta: a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties

(2013) Daniel Golan et al.   BMC Neurology

The serum 25-hydroxyvitamin D response to vitamin D supplementation is related to genetic factors, BMI, and baseline levels

(2013) Allan Didriksen et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Multiple sclerosis: Lessons from molecular neuropathology

(2013) Hans Lassmann   EXPERIMENTAL NEUROLOGY

Personalization of Multiple Sclerosis Treatments: Using the Chelation Therapy Approach

(2013) Sante Guido Zanella et al.   Explore-The Journal of Science and Healing

Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants

(2013) Rocco Rossano et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Sunshine and multiple sclerosis

(2013) Bruce V Taylor   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Childhood obesity is a risk factor for multiple sclerosis

(2013) Kassandra L Munger   Multiple Sclerosis Journal

Vitamin D and energy homeostasis—of mice and men

(2013) Roger Bouillon et al.   Nature Reviews Endocrinology

Efficacy of Fish Oil on Serum of TNFα, IL-1β, and IL-6 Oxidative Stress Markers in Multiple Sclerosis Treated with Interferon Beta-1b

(2013) V. Ramirez-Ramirez et al.   Oxidative Medicine and Cellular Longevity

Impact of Manganese Neurotoxicity on MMP-9 Production and Superoxide Dismutase Activity in Rat Primary Astrocytes. Effect of Resveratrol and Therapeutical Implications for the Treatment of CNS Diseases

(2013) Tiziana Latronico et al.   TOXICOLOGICAL SCIENCES

CYP24A1 inhibition facilitates the anti-tumor effect of vitamin D3 on colorectal cancer cells

(2013) János P Kósa   WORLD JOURNAL OF GASTROENTEROLOGY

A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial

(2013) Marios C Pantzaris et al.   BMJ Open

Omega-3 fatty acid-derived resolvins and protectins in inflammation resolution and leukocyte functions: targeting novel lipid mediator pathways in mitigation of acute kidney injury

(2013) Song Hong et al.   Frontiers in Immunology

Can we prevent or treat multiple sclerosis by individualised vitamin D supply?

(2013) Jan Dörr et al.   EPMA Journal

ω-3 Fatty Acid Treatment in Multiple Sclerosis (OFAMS Study)

(2012) Øivind Torkildsen et al.   ARCHIVES OF NEUROLOGY

Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms

(2012) T. Bellini et al.   JOURNAL OF BIOCHEMISTRY

High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women

(2012) Anna K Hedström et al.   Multiple Sclerosis Journal

The initiation and prevention of multiple sclerosis

(2012) Alberto Ascherio et al.   Nature Reviews Neurology

Interferon-  and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS

(2012) N. Stewart et al.   NEUROLOGY

Vitamin D Protects Human Endothelial Cells from H2O2 Oxidant Injury Through the Mek/Erk-Sirt1 Axis Activation

(2012) Lorella Polidoro et al.   Journal of Cardiovascular Translational Research

Vitamin D, multiple sclerosis and inflammatory bowel disease

(2011) Margherita T. Cantorna   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

The molecular basis of nutritional intervention in multiple sclerosis: A narrative review

(2011) P. Riccio   COMPLEMENTARY THERAPIES IN MEDICINE

The association between cigarette smoking and multiple sclerosis

(2011) Naghmeh Jafari et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Synthesis and biological activities of vitamin D-like inhibitors of CYP24 hydroxylase

(2011) Grazia Chiellini et al.   STEROIDS

Cytochromes P450 are essential players in the vitamin D signaling system

(2010) Inge Schuster   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

Stimulation of Sirt1-Regulated FoxO Protein Function by the Ligand-Bound Vitamin D Receptor

(2010) B.-S. An et al.   MOLECULAR AND CELLULAR BIOLOGY

Pharmacokinetic study of lipoic acid in multiple sclerosis: comparing mice and human pharmacokinetic parameters

(2010) Vijayshree Yadav et al.   Multiple Sclerosis Journal

Autoimmune associations in multiple sclerosis

(2010) Cris S. Constantinescu et al.   Nature Reviews Neurology

Lipoic Acid Attenuates Inflammation via cAMP and Protein Kinase A Signaling

(2010) Sonemany Salinthone et al.   PLoS One

Developmental omega-3 supplementation improves motor skills in juvenile-adult rats

(2009) Addolorata Coluccia et al.   INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE

Clinical implications of a possible role of vitamin D in multiple sclerosis

(2009) Charles Pierrot-Deseilligny   JOURNAL OF NEUROLOGY

Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis,

(2009) L. Shinto et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis

(2009) Lahar R Mehta et al.   Nature clinical practice. Neurology

Vitamin D as an immune modulator in multiple sclerosis, a review

(2008) Joost Smolders et al.   JOURNAL OF NEUROIMMUNOLOGY

Resveratrol inhibits MMP-9 expression by up-regulating PPAR α expression in an oxygen glucose deprivation-exposed neuron model

(2008) Gang Cheng et al.   NEUROSCIENCE LETTERS

The opposing effects of n−3 and n−6 fatty acids

(2007) Gerd Schmitz et al.   PROGRESS IN LIPID RESEARCH